Latest News

Study finds low relapse risk in young patients with Hodgkin lymphoma

The treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of their healthy peers.

Source link

Related posts

Vaccine drama on display in California’s Capitol


Medical News Today: Surgeons carry out spine surgery in the womb


Drug combination could be effective for treatment-resistant gonorrhea


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy